MORRIS PLAINS, N.J., Sept. 15, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, will provide a corporate overview at the 2009 UBS Global Life Sciences Conference to be held at the Grand Hyatt New York in New York City. The presentation, scheduled for Tuesday, September 22, 2009 at 12:30 p.m., can be downloaded simultaneously at http://www.immunomedics.com/1aboutus/present.pdf.
